ADIT 2019 Abstracts
Topics
We will accept abstracts related to any topic of T1DM and T2DM management:
-
Pharmacological management of T1 and T2 DM
-
Non pharmacological management
-
Lifestyle modification
-
Technologies
-
Complications & Comorbidities
-
Issues and dilemmas in clinical practice
Abstract submission checklist
-
It is mandatory to submit the abstract using online submission system (www.adit-conf.org).
-
The submission system will close on September 15, 2019.
-
Single author can submit two abstracts.
-
We will accept abstracts related to any topic of diabetes management.
-
Submitting author must disclose source of funding and his/hers potential COI.
-
It is sole responsibility of submitting author to obtain consent from all the participating authors.
-
Conference organizer assumes that submitting author contributed to the study in significant way.
-
Submitting author must register for the conference in seven days following acceptance notification. Failing to do so will result in automatic rejection of the abstract.
-
Submitting authors of accepted abstracts are entitled to early bird registration level until October 7, 2019.
-
The reviewers reserve the right to reject any abstract which does not meet the conference criteria.
-
All submitting authors will be notified of the outcome of their submission by October 1, 2019.
-
By submitting the abstract the authors consent to their abstract being reviewed and published in conference material and web page, where appropriate.
-
ADIT organizer reserves the right to edit an abstract for the conference program to meet formatting, space requirements and readability.
-
By submitting the abstract the author confirms accuracy of information and compliance with terms and conditions available on the web page: www. adit-conf.org.
Original
Paper has not been submitted to previous ADIT conferences
Authentic
Submitting author participated and contributed to study in significant way
Transparent
Disclosure of source of funding and potential COI
